Brostallicin Clinical Trial for Myxoid Liposarcoma
Status:
Unknown status
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
This is a Phase II, multicenter, open-label clinical trial designed to determine the efficacy
and safety of Brostallicin when administered once every 3 weeks in patients with myxoid
liposarcoma with (12;16) translocation. The primary objective of this study is to determine
the response rate following Brostallicin administration.